Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br. 2012 Feb; 94(2):257-64.
View in:
PubMed
subject areas
Administration, Oral
Administration, Oral
Aged
Aged
Anticoagulants
Anticoagulants
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Arthroplasty, Replacement, Knee
Double-Blind Method
Double-Blind Method
Drug Administration Schedule
Drug Administration Schedule
Enoxaparin
Enoxaparin
Female
Female
Fibrinolytic Agents
Fibrinolytic Agents
Humans
Humans
Injections, Subcutaneous
Injections, Subcutaneous
Male
Male
Middle Aged
Middle Aged
Perioperative Care
Perioperative Care
Postoperative Hemorrhage
Postoperative Hemorrhage
Pyrazoles
Pyrazoles
Pyridones
Pyridones
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
authors with profiles
Gary E Raskob